Insulin has been isolated from an extract of the pancreas of a salamander, the lesser siren Siren intermedia, and its primary structure was established as: A-chain, Gly-Ile-ValGlu-Gln-Cys-Cys-His-Asn-Thri''-Cys-Ser-Leu-Tyr-Gln-LeuGlu-Asn-Tyr-Cys^°-Asn, and B-chain, Val-Pro-Asn-Lys-ProLeu-Cys-Gly-Ala-Hisio-Leu-Val-Glu-Val-Met-Tyr-Phe-ValCys-Gly^o-Asp-Arg-Gly-Phe-Phe-Tyr-Pro-Ser-Ser-Thr ^o. Although those amino acid residues considered to constitute the receptor-binding region of insulin have been retained, siren insulin contains several substitutions (Gin Lys at B4, Ser Ala at B9, Ala Val at B14, Leu -> Met at B15, Leu Phe at B17, Pro -Ser at B28, and Lys
Ser at B29) of amino acid residues that are conserved in insulins from species of other amphibian orders. The biological activity of siren insulin was not investigated in this study but the substitutions at B28 (involved in dimer formation) and at B14 and B17 (involved in hexamer formation) may be expected to influence conformation and therefore biological potency. The data are consistent with the view that the Sirenoidea represent an early divergence from the ancestral stock of salamanders. © 1997 Academic Press
The family Sirenidae comprises two genera. Siren and Pseudobranchus, each containing two species (Moler ^ To whom correspondence and reprint requests should be addressed. Fax; (402) 280-2690. and Kezer, 1993) . Sirens are eel-like salamanders with tiny forelimbs but no hindlimbs or pelvic girdle and are generally found in muddy pools in the southeastern and central United States and Northern Mexico (Martof, 1974; Villela and Brandon, 1992) . The Sirenidae are usually assigned to a separate suborder, Sirenoidea, within the order Caudata (Duellman and Trueb, 1986) . However, the Sirenidae and Salamandridae have been placed together in the Salamandroidea (Estes, 1981) and some taxonomists have proposed placing the species in their own order, Trachystoma, within the subclass Lissamphibia (Cope, 1989; Zug, 1993) . Cladistic analysis based upon a combination of molecular and morphological characters places Sirenidae as the sister group of all other families of salamanders (Larson and Dimirdck, 1993) . Although the fossil record is incomplete, salamanders probably evolved during the later Permian and Triassic and the radiation of the modem families must have occurred by the late Mesozoic (Naylor, 1980) . The extinct Sirenid genus Habrosaurus is known from the late Cretaceous (Carroll, 1984) .
Despite the importance of Amphibia in phylogeny and in our understanding of the evolution of physiological processes, our knowledge of the structures and biological activities of amphibian regulatory peptides is largely confined to the Anura (frogs and toads) (Andersen et al, 1992) . Previous studies have led to the isolation and structural characterization of insulin from the toad Xenopus laevis (Anura: Pipidae) (Shulinder et al, 1989) , from a salamander, the three-toed amphiuma, Amphiuma tridactylum (Caudata: Amphiumidae) (Conlon et al, 1996) and from the caedlian, Typhlonectes nutans (Gymnophiona: Typhlonectidae) (Conlon et al, 1995) . We now extend these studies to describe the purification and characterization of iiisulin from an extract of the pancreas of the lesser siren. Siren intermedia Le Conte.
MATERIALS AND METHODS
Tissue extraction. Sirens (18 specimens of both sexes; weight 31-135 g; length 15-30 cm) were collected between February and April of 1996 at sites in Craighead County and Clay County, Arkansas. The animals had been actively feeding and were in breeding condition (large ovarian follicles in females). Pancreatic tissue (1.4 g), taken from animals sacrificed by immersion in tricaine methanesulfonate, was extracted with ethanol/0.7 M HCl (3/1 v/v; 900 ml) as previously described (Conlon et al, 1996) . After centrifugation (1600g for 1 hr at 4°), ethanol was removed from the supernatant under reduced pressure. Peptide material was isolated from the extract using Sep-Pak C-18 cartridges (Waters Associates, Milford, MA). Bound material was eluted with acetonitrile/water/trifluoroacetic acid (70/29/1, v/v/v) and freeze-dried.
Radioimmunoassay.
Insulin-like immunoreactivity was measured using an antiserum raised against pig insulin as previously described (Flatt and Bailey, 1981) .
Purification of siren insulin. The pancreatic extract, after partial purification on Sep-Pak cartridges, was redissolved in 0.1% (v/v) trifluoroacetic acid/ water (5 ml) and injected onto a 1 X 25-cm Vydac 218TP510 C-18 reversed-phase HPLC column (Separations Group, Hesperia, CA) equilibrated with 0.1% (v/v) trifluoroacetic acid/water at a flow rate of 2 ml/min. The concentration of acetonitrile in the eluting solvent was raised to 21% (v/v) over 10 min and then raised to 49% (v/v) over 60 min using linear gradients. Absorbance was measured at 214 and 280 nm and individual peaks were collected by hand. Fractions (2 ml) were collected and assayed for insulinlike immunoreactivity at a dilution of 1:30. The peak designated I (containing insulin-like immunoreactivity) ( Fig. 1 ) was rechromatographed on a 0.46 X 25-cm Vydac 214TP54 C-4 reversed-phase column equilibrated with acetonitrile/water/trifluoroacetic acid (210/789/1) at a flow rate of 1.5 ml/min. The concentration of acetonitrile in the eluting solvent was raised to 42% over 40 min using a linear gradient. Siren insulin was purified to near homogeneity, as assessed by peak symmetry, by chromatography on a 0.46 X 25-cm Vydac 219TP54 phenyl column under the same conditions used for the C-4 column.
Structural characterization.
Siren insulin (approximately 2 nmol) was incubated for 6 hr at room temperatiire with dithiothieitol (2 mg) in 0.1 M Tris-HCl/6 M guanidine hydrochloride buffer, pH 7.5 (0.4 ml) imder an atmosphere of argon. Cysteine residues were derivatized by addition of 4-vinylpyridine (3 ml) and the pyridylethylated A-and B-chains of insulin were separated on a 25 X 0.46-cm Vydac C-4 column under the conditions used for the purification of intact insulin (Fig. IB) .
Amino acid compositions were determined in duplicate by precolumn derivatization with phenylisothiocyanate (Bidlingmeyer et al, 1984) using an Applied Biosystems Model 420A derivatizer followed by reversed-phase HPLC with an Applied Biosystems Model 130A separation system. Hydrolysis (24 hr at 110° in 5.7 M HCl) of approximately 1 nmol of sample was carried out. Cysteine and tryptophan residues were not determined. The primary structures of the siren peptides were determined by automated Edman degradation in an AppUed Biosystems Model 471A sequenator modified for detection of phenylthiohydantoin (PTH) amino add derivatives under gradient elution conditions. Approximately l-mnol portions of the peptides were used. The detection limit for the PTH derivatives was 1 pmol.
RESULTS

Purification of Siren Insulin
The crude extract of the S. intermedia pancreas contained only a very low concentration (approximately 1 pmol/g tissue weight) of insulin-like immunoreactivity measured with an antiserum raised against pig insulin, and the immunoreactivity in serial dilutions of the extract did not diminish in parallel with the pig insulin standard. The pancreatic extract, after partial purification on Sep-Pak cartridges, was injected directly onto a semipreparative Vydac C-18 column, and the elution profile is shown in Fig. lA . Insulin-like immunoreactivity was associated with the single prominent peak designated I. Siren insulin was purified to near homogeneity (as assessed by symmetrical peak shape) by successive chromatographies on a Vydac C-4 column ( Fig. IB) and a Vydac phenyl column (Fig. IC) . The final yield of the pure peptide was 3 nmol.
Structural Characterization of Siren Insulin
The primary structures of the pyridylethylated Achains and B-chains of siren insulin were determined by automated Edman degradation and the results are shown in Table 1 . It was possible to identify without ambiguity phenylthiohydantoin-coupled amino acids for 21 cycles of operation of the sequenator during sequence analysis of the A-chain and for 30 cycles during analysis of the B-chain. The results of amino acid analysis demonstrated that the A-chain of siren insulin had the composition Asx 2.9 (3), Glx 4.0 (4), Ser 1.0 (1), Gly 1.0 (1), His 0.9 (1), Thr 0.8 (1), Tyr 1.7 (2), Val 0.6 (1), lie 0.6 (1), and Leu 2.0 (2) (mol residue/mol peptide). The composition of the B-chain was determined as Asx 2.3 (2), Glx 1.3 (1), Ser 2.0 (2), Gly 3.0 (3), His 1.0 (1), Arg 1.3 (1), Thr 1.0 (1), Ala 1.1 (1), Pro 2.9 (3), Tyr 1.7 (2), Val 3.8 (4), Met 0.4 (1), Leu 1.9 (2), Phe 2. Val (687) Asn (833) 4 Glu (379) Lys (996) 5 Gin (335) Pro (829) 6 Cys (433) Leu (644) 7
Cys (442) Cys (471) 8 His (235) Gly (592) 9 Asn (468) Ala (604) 10 Thr (91) His (216) 11 Cys (264) Leu (506) 12 Ser (26) Val (480) 13 Leu (145) Glu (249) 14 Tyr (153) Val (464) 15
Gin (125) Met (382) 16 Leu (129) Tyr (327) 17 Glu (79) Phe (302) 18 Asn (73) Val (395) 19 Tyr (68) Cys (217) 20 Cys (34) Gly (331) 21 Asn (21) Asp (353) 22 Arg (162) 23 Gly (316) 24 Phe (226) 25 Phe (239) 26 Tyr (189) 27 Pro (146) between the sequence analysis and the amino add composition data was good, demonstrating that the fuU sequence of the peptides had been obtained. The sKghtly low values for the amoimts of valine and isoleudne in the A-chain are consistent with the presence of an lie-Val bond in the molecule that is resistant to hydrolysis and the low value for the methionine composition of the B-chain is indicative of oxidation to the sulfoxide derivative. The data demonstrated that the siren insulin was >98% pure.
DISCUSSION
The primary structure of siren insulin is compared with the structures of the known amphibian insulins and with insulin from a mammal (the human) in Fig. 2 . The data show that siren insulin contains several substitutions of amino acid residues that are otherwise well conserved in insulins from these and other vertebrate taxa. Although those residues on the surface of the molecule that are considered to constitute the receptor-binding region (A1-A3, A5, A19, A21, and B22-B26) (Baker et al, 1988) have been retained, siren insulin contains several substitutions (Gin Lys at B4, Ser ^ Ala at B9, Ala ^ Val at B14, Leu ^ Met at B15, Leu Phe at B17, Pro -Ser at B28, and Lys Ser at B29) of amino acids that are identical in insulins from other amphibians and the human. There was not sufficient pure material to investigate the biological activity of siren insulin but certain of these structural features may be expected to influence conformation and biological potency relative to human insulin. In particular, among those residues in human insulin involved in dimer formation (B12, B16, B20, B24, B26, and B28), siren insulin contains the substitution Pro Ser at B28. Similarly, among those residues in human insulin involved in hexamer formation (B6, BIO, B14, B17, B18, A13, and A14), siren insulin contains the substitutions Ala
Val at B14 and Leu Phe at B17. On the other hand, siren insulin shares with insulins from the chicken (Simon et al, 1977) , Xenopus (Shulinder et al, 1989) , and the amphiuma (Conlon et al, 1996) the presence of a histidine residue at position A8. This residue, by forming stabilizing interactions with residues in the receptor, is believed to be responsible for the observed increase in binding affinity (between two-and fivefold) of these insulins for mammalian insulin receptors. The phylogenetic relationship between the sirenids and other salamanders is unclear as sirenids possess a peculiar combination of primitive and derived morphological characters, some of which are associated with paedomorphosis (Duellman and Trueb, 1986) . Recent analyses focusing on the oviducal and cloacal anatomy of S. intermedia have concluded that sirenids have retained external fertilization, the ancestral state for the Lissamphibia consistent with the hypothesis that they are derived from a basal stock of salamanders (Sever, 1991; Sever et al., 1996) . Siren insulin resembles most closely that of the amphiuma, consistent with the placement of these species within the order Caudata, but the presence of 12 amino acid substitutions is indicative of a relatively ancient divergence of the species. The A-chain of amphiuma insulin contains 23 amino acid residues, leading to the suggestion that multiple amino acid substitutions in the region of the Lys-Arg cleavage site linking the C-peptide region to the A-chain results in an anomalous pathway of proinsulin processing (Conlon et al, 1996) . The A-chain of siren insulin does not contain this unusual Nterminal dipeptide extension found in the amphiuma A-chain, indicating that siren proinsulin is processed to insulin in the conventional manner by the action of a SPC-2 type convertase (Steiner et al, 1992) . Phylogenetic studies comparing DNA sequences of mitochondrial ribosomal genes (Hedges et al, 1993) have supported the conclusion of earlier morphological investigations (Van der Horst et al, 1991) that the Gymnophonia and the Caudata are sister taxa. Siren insulin, however, contains 18 amino acid substitutions compared with the corresponding region of a caecilian insulin (Conlon et al, 1995) but only 14 substitutions compared with Xenopus insulin II (Shulinder et al, 1989) (Fig. 2) . This observation illustrates the pitfalls associated with inferring phylogenetic relationships between species based upon the amino acid sequences of their insulins (Bajaj et al, 1984; Conlon et al, 1990; Hedges et al, 1990; Dores et al, 1996) . Nevertheless, we feel there is a need to characterize insulins from a much wider range of amphibian species in order to ascertain whether meaningful phylogenetic inferences may be drawn based upon the structures of this hormone. Similarly, for those species from which appreciable amounts of pancreatic tissue may be obtained, a study of the biological properties of purified amphibian insulins will be of value in providing insight into structure-activity relationships.
